Open Label Study to Assess Efficacy & Safety of Olaparib in Confirmed

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03197896` - Educational Intervention in Increasing Knowledge About Prostate Cancer in High-Risk Neighborhoods	N/A
Completed	`NCT00026689` - Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
Completed	`NCT00547625` - Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems	Phase 2
Completed	`NCT00648323` - Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement	Phase 4
Completed	`NCT00579423` - Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer	Phase 2
Completed	`NCT00342433` - Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study
Active, not recruiting	`NCT03047135` - Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis	Phase 2
Enrolling by invitation	`NCT06364865` - AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study
Terminated	`NCT03197948` - Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment
Completed	`NCT00586898` - Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle	Phase 2
Recruiting	`NCT04518072` - Synthetic Metabolic and Genetic Networks for Medical Diagnosics
Completed	`NCT01118260` - Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection	Phase 4
Recruiting	`NCT00923221` - Collection of Blood From Patients With Prostate Cancer
Completed	`NCT00423254` - Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.	Phase 1
Terminated	`NCT02918227` - Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia	N/A
Completed	`NCT05509114` - The Effect of Virtual Reality Glasses Application on Pain, Anxiety, and Patient Satisfaction	N/A
Completed	`NCT02756975` - Prostate Core Needle Biopsy	N/A
Active, not recruiting	`NCT00572468` - Statin Therapy Versus Placebo Prior to Prostatectomy	N/A
Completed	`NCT00364455` - Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.	Phase 3
Terminated	`NCT03318367` - Virtual Reality Education Module in Reducing Anxiety and Increasing Knowledge in Patients With Prostate Cancer Undergoing Radiation Therapy	N/A

NCT number	NCT01078662
Study type	Interventional
Source	AstraZeneca
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	February 21, 2010
Completion date	December 31, 2024

Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms